Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries.

It follows that considerable research is directed at establishing effective treatment for acute vascular events.

Long-term treatment has also received considerable attention (e.g. for symptomatic relief).

Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved.

The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 2.1
2024 2.80

SJR (SCImago Journal Rank)

Year Value
2024 0.726

Quartile

Year Value
2024 Q2

h-index

Year Value
2024 71

Journal Rank

Year Value
2024 7739

Journal Citation Indicator

Year Value
2024 375

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
2.1
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.726
First Published: 2024

Quartile

Current Quartile
Q2
First Published: 2024

Similar Journals

Top Journals in Related Fields